The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (Veklury) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Remdesivir works to stop replication of SARS-CoV-2, the virus that…
Read moreThe U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (Veklury) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Remdesivir works to stop replication of SARS-CoV-2, the virus that causes COVID-19. Previously authorized by the FDA for emergency use to treat COVID-19, remdesivir is now the first and only
